Lindsay R Standeven1, Jennifer L Payne1,2, Meeta Pangtey1, Lauren M Osborne1,2. 1. Department of Psychiatry and Behavioral Sciences, Women's Mood Disorders Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 2. Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
OBJECTIVE: Peripartum depression is a leading contributor to peripartum morbidity and mortality. Despite the evidence for relative safety, many patients and providers remain reluctant to use or modify psychotropics in the peripartum period. We hypothesized that depressed women in the peripartum period taking psychiatric medications would not experience dose adjustments. METHODS: Women with a prior history of either Major Depressive Disorder or Bipolar Affective Disorder were followed through pregnancy and the postpartum period (N = 229). Depressive symptoms were measured with the Edinburgh Postnatal Depression Scale (EPDS), with a score ≥ 13 indicating likely depression. Data analysis included descriptive statistics, chi-square tests, and logistic regression. RESULTS: Antepartum depression was more common than postpartum depression (PPD; 29% vs. 20%); 38% of women with antepartum depression also had PPD. Regression analysis revealed that, although depressed women in pregnancy were not more likely to have a dose adjustment than nondepressed women (OR: 1.9, 95% CI: 0.8-4.6), depressed women in the postpartum were more likely to receive a medication change than nondepressed women (OR: 6.3, 95% CI: 2.0-20.4). CONCLUSIONS: In a naturalistic study, more medication adjustments for depression occurred in the postpartum than in pregnancy. This may indicate that antepartum depression is undertreated.
OBJECTIVE: Peripartum depression is a leading contributor to peripartum morbidity and mortality. Despite the evidence for relative safety, many patients and providers remain reluctant to use or modify psychotropics in the peripartum period. We hypothesized that depressed women in the peripartum period taking psychiatric medications would not experience dose adjustments. METHODS: Women with a prior history of either Major Depressive Disorder or Bipolar Affective Disorder were followed through pregnancy and the postpartum period (N = 229). Depressive symptoms were measured with the Edinburgh Postnatal Depression Scale (EPDS), with a score ≥ 13 indicating likely depression. Data analysis included descriptive statistics, chi-square tests, and logistic regression. RESULTS: Antepartum depression was more common than postpartum depression (PPD; 29% vs. 20%); 38% of women with antepartum depression also had PPD. Regression analysis revealed that, although depressed women in pregnancy were not more likely to have a dose adjustment than nondepressed women (OR: 1.9, 95% CI: 0.8-4.6), depressed women in the postpartum were more likely to receive a medication change than nondepressed women (OR: 6.3, 95% CI: 2.0-20.4). CONCLUSIONS: In a naturalistic study, more medication adjustments for depression occurred in the postpartum than in pregnancy. This may indicate that antepartum depression is undertreated.
Authors: Richard Wesseloo; Astrid M Kamperman; Trine Munk-Olsen; Victor J M Pop; Steven A Kushner; Veerle Bergink Journal: Am J Psychiatry Date: 2015-10-30 Impact factor: 18.112
Authors: Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe Journal: JAMA Date: 2006-02-01 Impact factor: 56.272
Authors: Isabella Pacchiarotti; Jordi León-Caballero; Andrea Murru; Norma Verdolini; Maria Antonietta Furio; Corinna Pancheri; Marc Valentí; Ludovic Samalin; Eva Solé Roigé; Ana González-Pinto; Jose Manuel Montes; Antonio Benabarre; Jose Manuel Crespo; Consuelo de Dios Perrino; Jose Manuel Goikolea; Luis Gutiérrez-Rojas; André F Carvalho; Eduard Vieta Journal: Eur Neuropsychopharmacol Date: 2016-08-24 Impact factor: 4.600